Both the incidence and mortality of lung cancer showed an increasing trend between 2015 and 2020, with an estimated 0.79 and 0.82 million new cases and 0.63 and 0.72 million deaths, respectively ( 5 ).
← all excerpts
Real world experience with camrelizumab in patients with advanced non-small cell lung cancer: a prospective multicenter cohort study (NOAH-LC-101).
1
—
—